MURA

Mural Oncology
MURA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$47.72M
EV
$-88.64M
Shares Outstanding
17.23M
Beta
-

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$5.00
P/E 2025E
-
P/Revenue 2025E
1.33x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Mural Oncology plc

gainify
MURA

Mural Oncology plc

MURA

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company’s lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherap...

Sector

Healthcare

Industry

Biotechnology

CEO

Loew, Caroline

Employees

116

IPO Date

2023-11-16

Headquarters

10 Earlsfort Terrace, Dublin D02 T380, Ireland

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved